• Targeted mRNA Nanoparticles Protect the Poststroke BBB

  2026-10-08

  Gao and colleagues developed mannose receptor-targeting lipid nanoparticles that deliver IL-10 mRNA to ischemic brain regions and shift microglial responses toward a protective state. In mouse stroke models, this strategy was associated with reduced neuroinflammation, improved blood–brain barrier integrity, less neuronal apoptosis, and better neurological outcomes, while remaining limited by preclinical evidence and model-specific biology.

• Protease Inhibitor Cocktail and Evidence Fidelity

  2026-10-08

  A scientifically grounded analysis of how a Protease Inhibitor Cocktail can protect protein evidence without being mistaken for proof of mechanism. It connects EDTA-free protease control with biomarker-based interpretation and clearly defines the limits of the evidence.

• KN-62: Mapping CaMKII in Calcium Signaling

  2026-10-07

  KN-62 is a selective CaMKII inhibitor used to examine calcium-dependent secretion, metabolism, and cell-cycle signaling. This article interprets its research value alongside a 2025 study identifying NLG1 proteolysis as a mechanism for social-memory maintenance, while clearly separating direct evidence from mechanistic inference.

• BX795 in TBK1, PDK1, and HBV Immunity

  2026-10-07

  BX795 is a research small-molecule kinase inhibitor used to examine PDK1, TBK1, and IKKε signaling. This overview evaluates its role in a 2025 HBV study, emphasizing mechanistic interpretation, evidence strength, pharmacological limitations, and boundaries for cancer and innate immune research.

• PEGylation and Targeted mRNA Polyplexes: Study Insights

  2026-10-06

  Folda and colleagues show that carefully selected PEGylated lipids can improve the colloidal stability, protein-corona behavior, and targeting potential of LAF–xenopeptide mRNA polyplexes without uniformly eliminating transfection activity. The study also clarifies the PEG dilemma: stronger surface shielding can reduce cellular delivery, whereas ligand-mediated targeting and carrier responsiveness may recover activity in selected cellular contexts.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody

  2026-10-06

  A supplier-described, HRP-conjugated polyclonal secondary antibody intended to recognize rabbit IgG heavy and light chains. No matched research paper evidence was provided, so performance claims and application-specific validation remain unconfirmed.

• TUNEL and PDK1 Signaling in Apoptosis Research

  2026-10-05

  TUNEL detects DNA fragmentation, but it does not independently establish apoptosis, caspase activation, or treatment mechanism. This overview places the One-step TUNEL Cy5 Apoptosis Detection Kit in the context of a 2025 pre-proof study linking KDM3A, METTL16, and PDK1 to tyrosine kinase inhibitor resistance, while comparing evidence strength, conceptual applications, and interpretive limitations.

• Quercetin, EGFR, and HBV-Associated HCC

  2026-10-05

  Wang et al. integrate cell-based, computational, molecular, and animal evidence to examine how quercetin affects HBV-associated hepatocellular carcinoma. Their results prioritize EGFR as a mechanistic target and connect quercetin exposure with reduced tumor-cell proliferation and migration, while leaving important questions about clinical translation and disease specificity unresolved.

• Clodronate Liposomes in Macrophage Research

  2026-10-04

  Clodronate Liposomes are used conceptually to test whether macrophages contribute to tissue injury, repair, or treatment response. This overview examines their research context, the 2025 hepatic ischemia-reperfusion study involving Tmem176b-positive macrophages, the strength of depletion and single-cell evidence, and important limits on interpretation and translation.

• Sulfo-Cy5 and the Next Wave of Translational Imaging

  2026-10-03

  A mechanistic and translational perspective on using Sulfo-Cy5 carboxylic acid to frame imaging questions around nanoparticle biodistribution, mucosal immunity, and biological mechanism—without overstating what fluorescence alone can prove.

• Berbamine hydrochloride in Cancer Workflows

  2026-10-02

  Berbamine hydrochloride supports integrated NF-κB, STAT3, viability, and ferroptosis-resistance studies in leukemia and hepatocellular carcinoma models. This practical workflow connects concentration planning and assay controls with the METTL16-SENP3-LTF findings that define a new way to test ferroptosis biology.

• DiR for MSC Tracking in Neurocognitive Research

  2026-10-01

  DiR (DiIC 18 (7)) converts hUC-MSC biodistribution into a measurable experimental variable in perioperative neurocognitive disorder studies. Its near-infrared membrane signal supports longitudinal cell tracking, tissue mapping, and stringent controls that separate localization from therapeutic mechanism.

• Cytochalasin B: Designing Better Actin Assays

  2026-10-01

  Cytochalasin B is more than an actin inhibitor: it is a reversible perturbation and assay-interpretation tool. Learn how to combine cytoskeletal readouts with orthogonal cytotoxicity and genotoxicity controls for more defensible research conclusions.

• Red Blood Cell Membrane Bending Rigidity Explained

  2026-09-30

  The reference study separates the lipid cytoplasmic membrane from the spectrin-supported red blood cell envelope and combines X-ray diffuse scattering, neutron spin-echo spectroscopy, and molecular dynamics simulations to measure its intrinsic bending rigidity. It reports a relatively soft membrane with a bending modulus of approximately 4–6 kBT, clarifying why measurements on intact cells can be substantially higher and scale dependent.

• DGLA–ACSL4 Ferroptosis in AML Cells

  2026-09-30

  The reference study identifies dihomo-γ-linolenic acid (DGLA) as a ferroptosis-promoting lipid in acute myeloid leukemia (AML) and links its activity to ACSL4-dependent lipid metabolic reprogramming. By combining targeted metabolomics, fatty-acid perturbation, ACSL4 knockout, and an in vivo dietary model, the work provides a mechanistic framework for targeting AML cells that may evade apoptosis.

8343 records 1/557 page Next 12345 下5页 Last page